about
Drivers for change in the management of prostate cancer - guidelines and new treatment techniques.Prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: a systematic review.Age-specific prostate specific antigen cutoffs for guiding biopsy decision in Chinese population.Future opportunities for the diagnosis and treatment of prostate cancer.Advanced prostate cancer treatment guidelines: European perspective.Technical considerations when obtaining and interpreting prostatic biopsies from men with suspicion of early prostate cancer: part 2.Evaluation and management of prostate-specific antigen recurrence after radical prostatectomy for localized prostate cancer.The National Prostate Cancer Register in Sweden 1998-2002: trends in incidence, treatment and survival.Lymph node staging in prostatic carcinoma revisited.Trends in primary androgen depletion therapy for patients with localized and locally advanced prostate cancer: Japanese perspective.Cancer in older men: a gender-based review.Towards rational and evidence-based use of melatonin in prostate cancer prevention and treatment.Appropriateness of Prostate Cancer Imaging among Veterans in a Delivery System without Incentives for Overutilization.Prostate cancer imaging trends after a nationwide effort to discourage inappropriate prostate cancer imagingA qualitative study to understand guideline-discordant use of imaging to stage incident prostate cancer.'They're doing surgery on two people': a meta-ethnography of the influences on couples' treatment decision making for prostate cancer.Combined Whole Body and Multiparametric Prostate Magnetic Resonance Imaging as a 1-Step Approach to the Simultaneous Assessment of Local Recurrence and Metastatic Disease after Radical Prostatectomy.Should high-grade prostatic intraepithelial neoplasia change our approach to infravesical obstruction?Geographical variation in incidence of prostate cancer in Sweden.Prostate cancer volume -- can it be predicted preoperatively?Should prostate cancer status be determined in patients undergoing radical cystoprostatectomy?Information seeking and satisfaction with physician-patient communication among prostate cancer survivors.High grade intraepithelial neoplasia of prostate is associated with values of prostate specific antigen related parameters intermediate between prostate cancer and normal levels.Prescription practice for LH-RH analogs and androgen receptor antagonists in the treatment of advanced prostate cancer in Germany (1993-2003).Radical prostatectomy--long-term oncological outcome from a community hospital.Screening for prostate cancer: are organized screening programs necessary?
P2860
Q34294112-B7C98160-2F41-4DC7-9C58-ED886C1CE486Q34439388-2946447D-02C0-4D92-9B7E-211456DA448EQ34795029-8A9CDDAF-1398-43B1-A7EC-2B7F37C783F8Q35886572-3D333C13-4033-47C9-AAD1-1D8B20AFE120Q35937038-36C482E5-2D41-4E47-B352-918AC89A31A3Q36118580-0DCA43EC-E1A0-4FB5-AB40-70C1123245DFQ36173646-1C3645DC-388F-482B-B224-E7A6521B6591Q36194987-0D8B210E-A1C8-4F76-B359-EA8A3DDD638FQ36258503-C6EBEBAC-2433-47A1-AEAE-B50195DB0BF1Q36456013-D7E19E3D-FB41-4D6C-9C98-C208BC7A941AQ36627783-CDD375F3-F6F5-4BB2-88D0-02F39A4601CEQ36872043-220DEEDF-8E46-43EA-A872-A28A26E9B1CCQ36922050-95F97259-A7DE-4D74-A819-B68F8F37EF30Q37141514-65AB86F9-9291-4C4D-B621-9AC964323ADDQ37230831-F3A0567C-0ECC-49C6-B017-EE2AD5B1D670Q37332598-5D484E28-F422-4537-AB39-0D74CAF0DBA2Q39143177-0AA08BC6-4AA8-4D6B-B16A-9FFCF6FBEF28Q39717008-7B83A7BB-2FB9-40D4-B29D-8DAE30BB2A87Q39734785-9F3A46C3-0F9E-4D84-93FC-A22A1A31B41CQ39738265-BB4856CC-243D-4B8B-904D-65F2F1321530Q39776834-D9031E50-35A4-4F02-9731-83667A3A3DA8Q40097991-0A22AC35-2D9A-44B3-84F3-6230943D93FEQ42102460-F398B225-5225-461D-A36B-E7B21155DFBDQ45174827-22B45BD4-680D-4F0D-922C-C749E32EC2EDQ47409301-07669D32-3E1B-49FE-9A4A-E0BB58D3C03FQ51733075-6EB51BF1-16DD-46A5-A91E-114472C3DFBE
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
EAU guidelines on prostate cancer.
@ast
EAU guidelines on prostate cancer.
@en
EAU guidelines on prostate cancer.
@nl
type
label
EAU guidelines on prostate cancer.
@ast
EAU guidelines on prostate cancer.
@en
EAU guidelines on prostate cancer.
@nl
prefLabel
EAU guidelines on prostate cancer.
@ast
EAU guidelines on prostate cancer.
@en
EAU guidelines on prostate cancer.
@nl
P2093
P356
P1433
P1476
EAU guidelines on prostate cancer.
@en
P2093
EAU Working Group on Oncological Urology
H P Schmid
H van Poppel
P304
P356
10.1159/000049758
P407
P577
2001-08-01T00:00:00Z